Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $24.94

0.16 (-0.64%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

PFE Price/Volume Stats

Current price $24.94 52-week high $31.54
Prev. close $25.10 52-week low $24.48
Day low $24.65 Volume 46,170,699
Day high $25.10 Avg. volume 38,445,105
50-day MA $28.36 Dividend yield 6.76%
200-day MA $28.12 Market Cap 141.33B

PFE Stock Price Chart Interactive Chart >


Pfizer Inc. (PFE) Company Bio


Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.


PFE Latest News Stream


Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream


Loading social stream, please wait...

View Full PFE Social Stream

PFE Price Returns

1-mo -12.18%
3-mo -12.36%
6-mo -9.80%
1-year -11.48%
3-year -43.42%
5-year -13.71%
YTD -6.77%
2023 -41.26%
2022 -10.41%
2021 66.69%
2020 3.23%
2019 -6.91%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!